Skip to main content

European Training Network for Excellence in Molecular Imaging in Diabetes

Ziel

Currently, 180 million people suffer from diabetes worldwide and this number is expected to double until 2030. Diabetes-related healthcare costs may rise to 40% of the total healthcare budget in high incidence countries. Despite these daunting numbers, our knowledge about the pathophysiology of T1D and T2D remains limited and many questions about the relation of the of the beta cell mass, the beta cell function and the metabolism of different tissues remain unanswered. In order to address these urgent questions, great hope has been put on the development of novel tracers, and functional and molecular imaging methods, which only recently have become available for in vivo diabetes imaging. However, it remains difficult to build up top level expertise as few, if any, European institutions are able to offer a profound combined molecular imaging/diabetes training, a shortcoming that continues to hamper the progress of the field. As a consequence, most available molecular imaging techniques are insufficiently characterised for clinical use in diabetes.
To address this challenge, we propose a training network (“BetaTrain”) to connect academic/private sector partners from 5 leading European FP7 consortia with top level expertise in beta cell/diabetes imaging. Like this, BetaTrain will not only provide a unique multidisciplinary intersectoral training opportunity to young scientists in the field, but will also address the urgent challenges in our combat against diabetes.
In order to non-invasively characterize beta cells and other relevant tissues in animal models and humans suffering from diabetes, it will be necessary to combine different molecular imaging techniques to provide information complementary to that obtained by other imaging, laboratory, and functional tests. The scientific training program of BetaTrain will therefore characterise, cross-calibrate and map these technologies/tracers in order to create the basis for personalised diagnosis and therapy in diabetes.

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2011-ITN
Andere Projekte für diesen Aufruf anzeigen

Koordinator

STICHTING RADBOUD UNIVERSITEIT
Adresse
Houtlaan 4
6525 XZ Nijmegen
Niederlande
Aktivitätstyp
Higher or Secondary Education Establishments
EU-Beitrag
€ 895 961
Kontakt Verwaltung
Maarten Van Langen (Mr.)

Beteiligte (9)

UMEA UNIVERSITET
Schweden
EU-Beitrag
€ 470 450
Adresse
Universitetomradet
901 87 Umea
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Ulf Ahlgren (Mr.)
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgien
EU-Beitrag
€ 461 604
Adresse
Oude Markt 13
3000 Leuven
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Elke Lammertyn (Dr.)
KAROLINSKA INSTITUTET
Schweden
EU-Beitrag
€ 236 871
Adresse
Nobels Vag 5
17177 Stockholm
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Helena Nässén (Ms.)
Institut klinické a experimentální mediciny
Tschechien
EU-Beitrag
€ 213 980
Adresse
Videnska 1958/9
14021 Prague 4
Aktivitätstyp
Research Organisations
Kontakt Verwaltung
Tomas Linhart (Mr.)
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Deutschland
EU-Beitrag
€ 456 549
Adresse
Geschwister-scholl-platz
72074 Tuebingen
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Bernd Pichler (Prof.)
UNIVERSITE DE GENEVE
Schweiz
EU-Beitrag
€ 492 860
Adresse
Rue Du General Dufour 24
1211 Geneve
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Paolo Meda (Prof.)
Scivis wissenschaftliche Bildverarbeitung GmbH
Deutschland
EU-Beitrag
€ 229 924
Adresse
Bertha-von-suttner-str, 5
37085 Göttingen
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Uwe Engeland (Dr.)
SANOFI-AVENTIS DEUTSCHLAND GMBH
Deutschland
EU-Beitrag
€ 229 924
Adresse
Bruningstrasse 50
65929 Frankfurt Am Main
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Alexandra Miranville (Dr.)
NOVO NORDISK A/S
Dänemark
EU-Beitrag
€ 293 547
Adresse
Novo Alle 1
2880 Bagsvaerd
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kontakt Verwaltung
Toby Alexander Brunt (Mr.)